Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | HTR2A | P28223 | 3/20 | 0.50 |
| ▸ | HRH1 | P35367 | 3/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL366705 | 1.00 | MEN1 (0.55) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| SCHEMBL774509 | 1.00 | MEN1 (0.55) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| Iodide SCHEMBL27880620 | 0.97 | MEN1 (0.53) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| Water SCHEMBL9747158 | 0.97 | MEN1 (0.53) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| Bromide SCHEMBL3879339 | 0.97 | MEN1 (0.53) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| Bromide SCHEMBL5789798 | 0.97 | MEN1 (0.53) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| SCHEMBL8405249 | 0.97 | MEN1 (0.53) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| Hydrochloric Acid SCHEMBL27284036 | 0.97 | MEN1 (0.59) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| Hydrochloric Acid SCHEMBL28035064 | 0.95 | MEN1 (0.57) | MEN1MAPTCYP2C9KMT2AKDM4E | |
| Hydrochloric Acid SCHEMBL28211053 | 0.95 | MEN1 (0.57) | MEN1MAPTCYP2C9KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760750-B1 | Process for preparing levoketoconazole | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2023-09-19 | — | — | US | claimed |
| CN-115093392-A | Preparation method of R-lipoic acid | 苏州富士莱医药股份有限公司 | 2022-09-23 | — | — | CN | claimed |
| US-8853390-B2 | Processes for preparing 1,2-substituted cyclopropyl derivatives | ABBVIE INC. (US) | 2014-10-07 | — | — | US | claimed |
| WO-2012037258-A1 | PROCESSES FOR PREPARING 1,2-SUBSTITUTED CYCLOPROPYL DERIVATIVES | ABBOTT LABORATORIES (US) | 2012-03-22 | — | — | WO | claimed |
| US-20120071651-A1 | Processes for Preparing 1,2-Substituted Cyclopropyl Derivatives | ABBOTT LABORATORIES (US) | 2012-03-22 | — | — | US | claimed |
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | CORN PRODUCTS DEV INC (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4561366-A1 | FLAVOR MODIFYING COMPOSITION | CORN Products Development Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| US-20250135005-A1 | PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES | TAMBO INC (US) | 2025-05-01 | — | — | US | disclosed |
| US-20250081996-A1 | FLAVOR MODIFYING COMPOSITION | PURECIRCLE SDN BHD (MY) | 2025-03-13 | — | — | US | disclosed |
| US-12194100-B2 | Processes for preparing functionalized cyclooctenes | TAMBO, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| EP-4380375-A1 | METHODS FOR THERMALLY INHIBITING STARCH | CORN Products Development Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024026450-A1 | FLAVOR MODIFYING COMPOSITION | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2006011045-A1 | PHOTORACEMIZATION OF 2-TRIFLUOROMETHYL-2H-CHROMENE-3-CARBOXYLIC ACID DERIVATIVES | WARNER-LAMBERT COMPANY LLC (US) | 2006-02-02 | — | — | WO | disclosed |
| WO-2006011052-A1 | METHOD FOR THE RACEMIZATION OF 2-TRIFLUORO-2H-CHROMENE-3-CARBOXYLIC ACIDS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-02-02 | — | — | WO | disclosed |
| US-20060020023-A1 | Racemization method | PHARMACIA & UPJOHN COMPANY LLC | 2006-01-26 | — | — | US | disclosed |
| US-20060016683-A1 | Photoracamization method | PHARMACIA & UPJOHN COMPANY LLC | 2006-01-26 | — | — | US | disclosed |
| US-20060020022-A1 | Enantioselective separation method | PHARMACIA & UPJOHN COMPANY LLC | 2006-01-26 | — | — | US | disclosed |
| US-20050043556-A1 | 2,2'-Bis(triphenylphosphino)biphenyls complexed with a transition metal-diamine complex; highly active and selective hydrogenation catalysts for the hydrogenation of ketones and imines to alcohols and amines, respectively, used as drug intermediates often required in single isomer form; very low loading | MALAN CHRISTOPHE GUILLAUME (CH) | 2005-02-24 | — | — | US | disclosed |
| US-20040186298-A1 | Novel use of sulfamic acids as resolving agent | AVANTIUM INTERNATIONAL B.V. (NL) | 2004-09-23 | — | — | US | disclosed |
| EP-1264814-A1 | Resolving agents based on amines | Avantium International B.V. (NL) | 2002-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | TAS2R42, TAS2R7, TAS2R31 | MEN1 2084/4885MAPT 973/4885CYP2C9 1554/4885 |
| US-12194100-B2 | Processes for preparing functionalized cyclooctenes | PPOX, SCO2, CYCS | MEN1 2903/4885MAPT 4086/4885CYP2C9 857/4885 |
| US-20060020023-A1 | Racemization method | STS, SQLE, HAO2 | MEN1 2567/4885MAPT 4565/4885CYP2C9 24/4885 |
| US-20250135005-A1 | PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES | PPOX, SCO2, CYCS | MEN1 2903/4885MAPT 4086/4885CYP2C9 857/4885 |
| US-20050043556-A1 | 2,2'-Bis(triphenylphosphino)biphenyls complexed with a transition metal-diamine complex; highly active and selective hydrogenation catalysts for the hydrogenation of ketones and imines to alcohols and amines, respectively, used as drug intermediates often required in single isomer form; very low loading | ADH5, ADH1A, ADH1C | MEN1 2180/4885MAPT 2945/4885CYP2C9 42/4885 |
| US-20120071651-A1 | Processes for Preparing 1,2-Substituted Cyclopropyl Derivatives | HRH3, HRH4, HRH1 | MEN1 1009/4885MAPT 2094/4885CYP2C9 425/4885 |
| US-20060016683-A1 | Photoracamization method | CYP3A43, CRY2, CRY1 | MEN1 3263/4885MAPT 2006/4885CYP2C9 29/4885 |
| US-20060020022-A1 | Enantioselective separation method | SLC7A1, SLC10A1, DHCR7 | MEN1 3502/4885MAPT 3454/4885CYP2C9 184/4885 |
| US-11760750-B1 | Process for preparing levoketoconazole | KHK, KYAT3, PLK3 | MEN1 2073/4885MAPT 1668/4885CYP2C9 108/4885 |
| US-20040186298-A1 | Novel use of sulfamic acids as resolving agent | HAO1, FPR1, DAO | MEN1 4130/4885MAPT 4682/4885CYP2C9 2103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.